tissue regeneration

Improving surgical performance with innovative tissue regeneration solutions from the Nordics.

Freedom to operate

At Biomendex, our mission is to give surgeons the freedom to operate and concentrate on what is most important: the patient.  

We believe that our innovative and versatile bone graft substitutes can provide improvements in surgical outcomes and minimize operational risks.


Biomendex develops Adaptos® bone graft substitutes for various surgical indications. In addition to clinical use Adaptos® products are available for veterinary surgeries.

Clinical products

Adaptable solutions for the whole skeletal system

Adaptos® bone graft substitutes are easy to shape and use even in demanding operations. Adaptos® products are being developed for various surgical indications, including oral & maxillofacial, orthopedic, and spine. 

Veterinary products

The first truly adaptive bone graft for veterinaries

Adaptos®Vet products enable superior handling qualities and operational performance for veterinary surgeons. Our Adaptos®Vet products are already available for treatment of veterinary patients.


See the latest updates about Biomendex.

Pasi Kankaanpää starts as the CEO of Biomendex on the first of March 2023

Pasi Kankaanpää will start as the CEO of Biomendex on the first of March 2023. Kankaanpää has a strong background in the international medical device markets and in leading expert organizations. For the past seven years, he has…

Read more »

Adaptos® clinical study started with Hospital Orton, Oral and Planmeca

The first clinical study with Adaptos® bone grafts has started, and the first patients were operated on in beginning of June 2021. Sponsored by the Research Institute Orton, the study is conducted in collaboration with…

Read more »

Biomendex closed 1 M€ investment round

Biomendex, Tampere-based tissue technology company, recently closed 1M€ investment round. The new funding will be used to further accelerate product development, clinical trials and commercialization of Adaptos® bone graft substitute. The round was lead by…

Read more »

Adaptos® technology

Adaptos® adaptable bone graft substitutes provide synthetic solutions for the whole skeletal system. The unique composite material of Adaptos® is a combination of the best structural and functional features of both gel-like and ceramic bone graft substitutes. 

With high level of bioactivity and press-fit implantation,  Adaptos® locks in its place during implantation and integrates into bone tissue through natural bonding. Natural bone-like structure and optimal porosity enable tissue ingrowth and bone formation inside the material, which are essential for bone regeneration.

Adaptos® properties

 Adaptos® is the first bioactive bone graft substitute that surgeons can cut, shape, squeeze, and pack into place. It is the only bone graft substitute that mimics bone by being resilient and has durable structure that recovers after compression.

 Adaptos® is squeezable, and it stretches. Unbreakable material is designed to perform even in toughest spots.

Shape it as you wish.  Adaptos® will not break or crumble under the strain.

Cut  Adaptos® with scissors to fit any shape.

Resilient and elastic  Adaptos® can be packed to fill even the smallest voids. 


Adaptos® bone graft substitutes are being developed for various surgical indications, including oral & maxillofacial, orthopedic and spine. Adaptos®Vet products are already available for veterinary surgeries.

Become a distributor

Interested in distributor partnership for Adaptos®Vet?

 Adaptos®Vet is Biomendex’s highly competitive adaptable bone graft substitute product line for veterinarians. We are currently open for new distributor proposals especially in Europe.

If you have the industry experience and insight, great client network and the pioneer mindset that is needed to launch new products in your market, please contact us for more information.

Research partnerships

Groundbreaking technology at your fingertips

Biomendex is currently carrying out several studies in collaboration with its research partners. Our partners include major medical and vet service providers, such as Hospital Orton, Oral, Planmeca, and Evidensia.

We are currently open for new research partnerships especially in Europe for our new clinical study. Please contact the Biomendex team for more information.